[ad_1]
Unlike the vaccine developed by the American Pfizer and the German BioNTech which requires very low temperatures (-70ºC).
LThe vaccine that Sanofi is developing against Covid-19 for release in June 2021 will not need to be stored in the freezer, Sanofi France President Olivier Bogillot told CNews on Sunday.
Unlike the vaccine developed by the American Pfizer and the German BioNTech, which is in the lead but requires very low temperatures (-70ºC) to be stored, “our vaccine will be like the flu vaccine, you can put it in your refrigerator”, he pointed out. Olivier Bogillot: “We will not have this trap, it will be an advantage for some countries”.
One or two doses
The vaccine could be distributed “from June 2021,” said Olivier Bogillot, giving details of the program. The results of the phase 2 studies “involving several hundred patients” are expected to be made public in early December and are not “negative,” he said.
If these results prove positive, Sanofi will launch phase 3 studies “on several tens of thousands of patients” and take the “risk” of “launching production simultaneously”. Phase 3 results are therefore expected to be published in May. The lab still doesn’t know if it will take “one or two doses” for the vaccine to be effective.
.
[ad_2]
Source link
